First National Corp Amgen Inc Transaction History

First National Corp

$482 Million
Q2 2025

A detailed history of First National Corp transactions in Amgen Inc stock. As of the latest transaction made, First National Corp holds 1,969 shares of AMGN stock, worth $597,709. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,969

Previous 1,983 0.71%

Holding current value

$597,709

Previous $617,000 11.02%

% of portfolio

0.11%

Previous 0.14%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 08, 2025	SELL	$262.28 - $309.85 $3,671 - $4,337	-14 Reduced 0.71%	1,969 $549,000
Q1 2025 Apr 11, 2025	SELL	$258.59 - $327.36 $55,596 - $70,382	-215 Reduced 9.78%	1,983 $617,000
Q4 2024 Jan 29, 2025	SELL	$258.78 - $328.31 $24,842 - $31,517	-96 Reduced 4.18%	2,198 $572,000
Q3 2024 Oct 08, 2024	SELL	$309.38 - $337.38 $11,137 - $12,145	-36 Reduced 1.55%	2,294 $739,000
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $23,647 - $28,737	-90 Reduced 3.72%	2,330 $728,000
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $53,697 - $60,576	210 Added 9.5%	2,420 $697,000
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $4,810 - $5,972	-22 Reduced 0.99%	2,210 $593,000
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $28,497 - $33,698	133 Added 6.34%	2,232 $495,000
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $40,642 - $49,536	-180 Reduced 7.9%	2,099 $507,000
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $24,277 - $30,847	106 Added 4.88%	2,279 $0
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $2,693 - $3,037	-12 Reduced 0.55%	2,173 $490,000
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $7,613 - $8,472	-33 Reduced 1.49%	2,185 $531,000
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $10,524 - $11,643	-48 Reduced 2.12%	2,218 $536,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $45,742 - $52,348	-230 Reduced 9.21%	2,266 $510,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $79,176 - $92,765	373 Added 17.57%	2,496 $531,000
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $66,570 - $73,854	-285 Reduced 11.84%	2,123 $501,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $23,744 - $27,670	107 Added 4.65%	2,408 $599,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $15,579 - $18,552	72 Added 3.23%	2,301 $529,000
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $24,872 - $27,660	106 Added 4.99%	2,229 $743,000
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $19,187 - $23,545	97 Added 4.79%	2,123 $501,000
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $61,597 - $81,694	338 Added 20.02%	2,026 $550,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $19,299 - $24,806	102 Added 6.43%	1,688 $407,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $28,554 - $34,213	164 Added 11.53%	1,586 $307,000
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $17,503 - $20,518	-105 Reduced 6.88%	1,422 $262,000
Q1 2019 Jun 12, 2019	BUY	$180.87 - $203.88 $12,480 - $14,067	69 Added 4.73%	1,527 $6.89 Million
Q4 2018 Jun 12, 2019	BUY	$178.4 - $208.25 $260,107 - $303,628	1,458 New	1,458 $284,000

Others Institutions Holding AMGN

# of Institutions

3,286

Shares Held

426M

Call Options Held

7.45M

Put Options Held

7.46M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $162B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.

Account

First National Corp Amgen Inc Transaction History